Asimov, Inc.

About Asimov, Inc.

Asimov develops a cloud-based genetic design platform that combines synthetic biology, cloud lab automation, and machine learning to accelerate the engineering of living cells for therapeutic production. The company provides DNA assembly, strain optimization, and predictive modeling tools that let biotech and pharmaceutical R&D teams design, simulate, and order engineered cell lines and genetic constructs without maintaining in-house labs.